ImVitro vs MedArkive: Revenue, Funding & Team Size Compared
ImVitro generates $100.3K in revenue; MedArkive generates $151.7K. MedArkive is 1.5× bigger than ImVitro by revenue. The table below compares ImVitro and MedArkive on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company |  ImVitroThis company |  MedArkive |
|---|---|---|
| Revenue | $100.3K | $151.7K |
| Team size | 18 | 9 |
| Founded | 2019 | 2013 |
| HQ | Paris, France | London, United Kingdom |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
ImVitro at a glance
ImVitro generates $100.3K in revenue with 18 employees, headquartered in Paris, France.
- Revenue
- $100.3K
- Team size
- 18
- Founded
- 2019
ImVitro is a medical device developer that offers a SaaS platform that applies AI to In vitro fertilization imaging needs.
MedArkive at a glance
MedArkive generates $151.7K in revenue with 9 employees, headquartered in London, United Kingdom.
- Revenue
- $151.7K
- Team size
- 9
- Founded
- 2013
MedArkive is a SaaS pharma educational Content.
Other ImVitro alternatives
ImVitro competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
ImVitro vs MedArkive: frequently asked questions
Is ImVitro or MedArkive bigger?
MedArkive is the bigger company by revenue, at $151.7K against $100.3K for ImVitro.
How much revenue does ImVitro make?
ImVitro generates $100.3K in annual revenue with a team of 18.
How much revenue does MedArkive make?
MedArkive generates $151.7K in annual revenue with a team of 9.